Exam 4 Flashcards
oral contraceptives decrease risk of…
ovarian cancer
colon cancer
endometrial cancer
benign breast disease
ovarian cysts
endometriosis
fibroids
ovulation pain
PMS, PMDD
oral contraceptives may improves
Acne
Hirsutism
What day should po contraceptives be started
First day of menses or sunday after first day
Education for starting pt on po contraceptive
use backup birth control method for first 7 days
Reasons to choose progestin only contraceptives, depo-provera, IUD or nexplanon
Hx smoking
Over age 35
Abnormal vaginal bleeding
DM with vascular complications
DVT
PE
Ischemic heart disease
Breast cancer
Headache with focal neuro symptoms
Who cannot use nexplanon
History of hepatic disease or thrombosis
OBC choice for endometriosis
monophasic continuous therapy
OBC choice for post-partum/lactating
progesterone only (mini pill)
OBC choice for noncompliant patient
Depo shot, subdermal implant
OBC choice for breakthrough bleeding in first half of cycle
High estrogen content in first half of cycle
OBC choice for breakthrough bleeding in second half of cycle
High progestin content in first half of cycle
OBC choice for adolescent, peri-menopausal, post-partum nonlactating, and no medical risks
Any OCP <50mcg EE
Serious side effects of oral contraceptives
Increased risk of:
VTE
MI/Stroke (esp over 35 y/o)
Liver disorders
Frequency of depo-provera
every 13 weeks. If presenting after 13 week mark, must take pregnancy test first
Hormones in depo-provera
Progestin only
When to start depo-provera
Within 5 days after menses
Side effects of depo-provera
Weight gain, HA, dizziness, nervousness, amenorrhea, irregular bleeding
Effect of depo-provera on fertility
Slower reversal: 70% of women can conceive within the first year and 90% within the first 2 years. Not best choice if wanting to get pregnant right away after stopping. Discuss family planning before starting.
Depo-provera is safer choice for women with….
CV disease, stroke, VTE, PVD, and sickle cell disease
Efficacy rate of IUD
<1% risk of failure
Education for IUD
Easily reversible
Hormonal (progestin) and non-hormonal options
Maintenance is checking strings after period
Good choice for dysmenorrhea, menorrhagia, and anemia
SE of IUD
PID
Ectopic pregnany
Uterine perforation
Expulsion
Ovarian cysts
Irregular bleeding
Amenorrhea
Pelvic pain
Contraindication of IUD
Suspected pregnancy
Uterine abnormalities
PID
Unexplained vaginal bleeding
Contraception that has decreased efficacy in pts with high BMI
Xulane transdermal patch
-Increased failure rate and risk of VTE in patients with BMI >30 or over 198lbs
Best practices for using emergency contraception
1) Use within 5 days of unprotected sex but 3 days in best
2) Perform pregnancy test if no period within 21 days
3) Works by preventing ovulation
Drug options for emergency contraception
1) Copper IUD - most effective and offers long term protection up to 10 years
2) Levonorgestral (LNg, Plan B, Julie) -94% or less effective, best within 3 days, less effective for women over 165lbs
3) Ulipristal Acetate (UPA or Ella) - 98% effective, best within 3 days, less effective if over 195 lbs
4) Yuzpe (combo) - less effective, causes N/V
First Line Treatment for VVC (yeast infection)
OTC monistat (tioconazole, miconazole, clotrimazole) X 1-7 days
OR
Diflucan (fluconazole) PO 1 time dose
Second Line Treatment for VVC
Cultures for recurrent VVC
7-14 days topical
PO Fluconazole q72h x3 doses
Third Line Treatment for VVC
Referral
10-14 days topical OR
PO fluconazole maintence therapy 1x a week for 6 months
First Line Treatment Trichomonas
Metronidazole or Tinidazole 2g single dose
OR
Metronidazole 500mg BID x 7 days
Must also treat sex partners.
Avoid sex until treatment complete and symptom-free
Second Line Treatment Trichomonas
Try alternative 1st line option and refer to a specialist after recurrent failure
First Line Treatment Bacterial Vaginosis
PO metronidazole, topical clindamycin cream, metronidazole gel intravaginally
Education for treatment of BV
Metronidazole and Tinidazole - can cause n/v if alcohol ingested during treatment or w/in 72 hours after stopping
Avoid tight fitting clothes, allow ventilation, avoid douching or other hygiene products, avoid scented products that may alter pH
Instill vaginal creams and suppositories at bedtime and wear pad or pantyliner
Menopause hormone therapy for patient WITH uterus
Systemic estrogen (po or transdermal) PLUS progestin.
Estrogen alone can cause endometrial hyperplasia/cancer
Menopause hormone therapy for patient WITHOUT uterus
Estrogen alone
Hormone therapy contraindications
Estrogen-dependent neoplasia, thrombophlebitis/thromboembolic disorder, pregnancy, vaginal bleeding, uncontrolled HTN, acute liver disease
Monitoring for patients taking hormone therapy
1) Follow up 4-8 weeks after initiation and then every 3-6 months
2) Reevaluate yearly
3) Continue mammograms, Paps, and DEXA scans
4) Height/weight, lipids, BP, breast exam, full pelvic exam
5) stop 1-3 years after menopause
6) stop gradually to reduce rebound symptoms
7) risk of breast cancer if used over 3-5 years
Best treatment for vasomotor symptoms of menopause when hormone therapy contraindicated
SSRI
SNRI
Gabapentin
Clonidine
SSRIs for VMS
Paxil, Zoloft, Celexa, Lexapro
SNRIs for VMS
Effexor, Pristiq
Best route of treatment for Genitourinary syndrome of menopause (GSM)
Hormonal: Low dose vaginal estrogen OR transdermal estrogen OR ospemifene
Transdermal and vaginal have lower risk of VTE compared to oral.
Non-hormonal: Vaginal lubricant and moisturizers, continued sexual intercourse
Medications used to treat Pelvic Inflammatory Disease
Cephalosporins (ceftriaxone)
Doxycycline
Clindamycin
Gentamycin
Probenecid
Metronidazole
Empiric, broad spectrum coverage of ALL likely pathogens
Treatment of mild to moderate Pelvic Inflammatory Disease
Parenteral or PO/IM treatment with cephalosporins, doxycycline, clindamycin, gentamycin, probenecid, or metronidazole
Treatment of Severe Pelvic Inflammatory disease
Parenteral therapy with transitioin to PO within 24-48 hours after symptom improvement
Treatment of Gonorrhea in patients allergic to Cephalosporins
Gentamycin IM PLUS azithromycin PO
Suppressive therapy for Genital Herpes
Acyclovir, Valacyclovir, Famciclovir
Acyclovir has more frequent dosing due to low bioavailability so compliance may be harder
Genital herpes treatment for pregnant women
Acyclovir or valacyclovir
Treatment of Chlamydia for pregnant patient
Azithromycin 1g PO x 1 dose
Amoxicillin is alternative
Doxycycline is contraindicated in 2nd and 3rd trimester
Retest 3-4 weeks after treatment and again after 3 months to make sure it doesn’t pass to child
Patient Applied treatment for Genital Warts
Imiquimod (aldara): apply with finger at bedtime for up to 16 weeks. Wash off after 6-10 hours.
Podofilox (Condylox): Apply with cotton swab or gel with finger BIDx3 days, then no therapy for 4 days. Repeat 4 cycles.
Sinecatechins (green tea extract): Apply up to 3x/day for up to 16 weeks. DO NOT wash off.
Treatment for Syphilis in pregnant patient with allergy to Penicillin
PCN G is only effective treatment during pregnancy. Must desensitize mom to PCN and treat with PCN G. Allows temporary tolerance.
Contraindications of Phosphodiasterase-5 inhibitors
Do not use with Nitrates - causes extreme hypotension
Alpha blockers, angina, hypotension, uncontrolled HTN, recent stroke, arrhythmias, MI w/in 6 months, severe HF, renal failure, liver failure, potent CYP450 inhibitors
First Line treatment of erectile dysfunction
Phosphodiasterase-5 Inhibitors:
Cialis
Vardenafil
Sildenafil
Avanafil
Considerations for Cialis
Long MOA, avoids need to plan for sex, 30 min onset
Consideratons for Vardenafil
60 min onset, decreased absorption with fatty foods
Considerations for Sildenafil
Take 30-60 minutes before sex, 3-5hr half life, decreased absorption with fatty foods
Considerations for Avanafil
Take 15 min before sex, half life 5-10 hrs
Second line treatment for ED
Refer to urologist
Complimentary treatment for ED
yohimbine, gingko biloba, ginseng, HCG, l-argine
MOA of antimuscarinics
Inhibit binding of acetylcholine at muscarinic receptors M3 on detrusor smooth muscle cells, causing relaxation and increasing bladder filling capacity
SE of antimuscarinics
Anticholinergic side effects: Constipation, dry mouth (xerostomia), urinary retention
Contraindication of antimuscarinics
Narrow angle glaucoma, urinary retention, other CYP450 drugs
Names of Antimuscarinics for overactive bladder
Oxybutynin/Ditropan
Tolterodine/Detrol
Solifenancin/Vesiare